Are you interested in stopping FDA's efforts to destroy natural medicines?
Yes No
The Alliance For Natural Health

The Pulse of Natural Health Newsletter

Stay informed about what is hot in Washington and the states about natural health

Ban Fish Oil Imports?

16

That is what a Pharma firm lawsuit seeks to do. It also opens up a novel front in the war on natural products by asking the US International Trade Commission to help create a new monopoly by knocking out imported EPA, the most anti-inflammatory kind of fish oil. Urgent Action Alert!

Amarin, the maker of an omega-3 drug, is taking the first steps to corner an important part of the fish oil market by asking the US International Trade Commission (ITC) to ban the importation of omega-3 dietary supplements that are composed mainly of the omega-3 known as  EPA (not to be confused with the federal agency). EPA is best known for its anti-inflammatory properties. Banning one of the most anti-inflammatory of foods, with inflammation linked to so many illnesses, with so many in pain, and with a pain prescription drug crisis going on, strikes us as almost unbelievable.  Will we let another important,  affordable, natural food or supplement be turned into a costly and difficult to obtain drug?  Note also that this opens a new front in the war on natural products by going to ITC rather than the FDA or FTC to try to create a new monopoly.

Here are some more resources on the importance of omega-3’s and the differences between them.

 

From Seeking Alpha

Amarin (NASDAQ:AMRNfiles a lawsuit with the U.S. International Trade Commission seeking a ban on the importation of omega-3 dietary supplements that are mainly comprised of the ester form of omega-3 called EPA. It wants the ITC to issue a general exclusion order prohibiting the importation of such products claiming the unregulated offerings represent “injurious unfair competition” to Vascepa [icosapent ethyl], approved by the FDA in July 2012 to reduce triglyceride levels in people with severely elevated levels of triglycerides. It also seeks a cease-and-desist order for all inventory of said products already in the U.S.

Share.